INTRODUCTION * * * *
Thrombosis is a condition of the blockage of blood vessel by fibrin clots that cause an acute myocardial infarction and stroke, and becoming leading of death [1] . In 2007, Ministry of Health stated that the highest rate of death has changed from infectious to degenerative diseases, and stroke has the leading causes of death [2] . The incidence of heart diseases has related to lifestyle changes [3] .
Thrombolytic agents are the major options than surgery. It works as plasminogen (PG) activator by changing inert PG enzymatically in the fibrinolytic system becomes plasmin (PN) and dissolves the fibrin clot into soluble degradation products, and then degradation products will be phagocyte [1, 4] . Several fibrinolytic drugs commonly used are streptokinase (SK), urokinase (UK), and tissue plasminogen activator (tPA) [4, 5] .
The drug selection is dependent on the price, side effect, severity, in vivo stability, specificity to fibrin, and immunological reactions. UK and tPA are immunological inert, but has a lower in-vivo stability and more expensive than SK that is naturally secreted from Streptococcus pyogenes M12 strain CS24 [5] .
Biotechnological research at School of Pharmacy ITB has developed several mutants of streptokinase (SKA) to obtain better in vivo activity which is associated with increasing of its biological half life and low immunological reaction. Based on the in-vitro experiments, the observation of pharmacological parameters and in vivo stability has to be explored [6] . Nuclear technique is a method of choice to observe this study. The advantages of this method are more sensitive, simple, and need only small sample to be analyzed. The preparation of SKA labeled iodine-131 as a tracer to be used in this research has been investigated. There are many methods of protein labeling with radioiodine, mostly oxidative reaction. Iodine-131 have been proven to be appropriated for labeling both small and large bio-molecules, protein or peptides, well known chemistry, availability easier, and low cost [7] .
EXPERIMENTAL METHODS
The materials used were Iodine-131 as Na 131 I solution (PT BATAN Technology), Bovine Serum Albumine (TCI), N,N,N',N'-tetramethiletilene diamine (TEMED), coomassie blue R-250 (Pharmacia), protein marker (Amersham), chloramine-T (Sigma), sodium metabisulfite (Merck), Whatman no. 1 paper, and DOWEX 1x8 (Merck). The equipment used were protein electrophoresis (Bio-Rad), paper chromatography apparatus, dose calibrator (RI Deluxe Iisotop Calib II, Victoreen) and single channel analyzer (ORTEC). Streptokinase were obtained from Overproduction of Escherichia coli BL21 (DE3) consist of pET-32b ska.
Animals
Male Swiss mice with age of 3 months, and body weight of 40-45 g were used for pharmacokinetic study. Animals used in the experiments received care in compliance with the "Principles of Laboratory Animal Care" and "Guide for the Care and Use of Laboratory Animals" [8, 9] .
Over-production of SKA
The SKA Over-production was performed on E.coli BL21 (DE3) containing pET-32b. Single colony of E.coli inoculated in 10 ml of liquid Luria Bertani broth containing 100µg/ml ampicillin as a selective medium. The culture was incubated for about 18h in a shaking incubator at 37 o C, and then a total of 10 mL of medium inserted into 200 mL selective medium. Cultures were re-incubated for 3 h at 37°C in a shaking incubator until OD 600 reached 0.3 to 0.4. Furthermore, the culture was induced with 0.5 mM IPTG and incubation was continued for an additional 3 hours, and then centrifugated at 4 o C, 4500g for 15 min. Pellet cells obtained from sediment was re-suspended in 5 mL of lysis buffer (50 mM NaH 2 PO 4 and 300 mM NaCl at pH 8.0) and PMSF to get a final concentration of 1 mM, and lyzed by sonication at the amplitude of 15 for 5 minutes. To prevent temperature elevation, the cells were sequentially sonicated and cooled on ice for several times, each time for 30s. Soluble protein were separated by centrifugation at 12,000 g, 4°C for 15 min, and then purified using nickel affinity column according to the manufacturer's protocol (Protino® Ni-Ted), and characterized by SDS-PAGE. Protein concentration was determined using Bradford method based on coomassie blue staining.
Labeling optimization of SKA with Iodine-131
SKA were labeled using radioiodine-131. The solution containing 6.2 µg of SKA in 50 µL PBS pH 7.4 was added to the amount of chloramine-T (1 mg / mL) which varied from 10-250µg. The solution was then shaked in a vortex mixer for 30 and 60 seconds at room temperature. To stop the reaction immediately, the sodium metabisulfite solution with a concentration of 2 times the concentration of chloramine-T was added [10, 11] .
Purification of 131 I-SKA
Dowex 1x8 (Cl-) was first activated with 1 N HCl solution for 1 hour, then washed with water until neutral pH. Three different weights of Dowex (100, 500 and 1,500mg) was inserted into the column with a ± 1cm diameter, and rinsed with 0.02 M phosphate buffer pH 7.5. The labeled 131 I-SKA was passed to the Dowex column and then eluted with 0.02 M phosphate buffer pH 7.5 containing 1% BSA and 0.1% KI [10] . 0.5-mL of each fraction was collected and measured with a dose calibrator. The radiochemical purity was then determined by using chromatography system.
Radiochemical purity determination of 131 I-SKA
Radiochemical purity was determined by ascending paper chromatography method using stationary phase Whatman no. 1, and the mobile phase of methanol-water (85:15). Paper chromatogram was dried in oven at 80°C for 5 minutes and then every 1 cm piece of paper is measured by the single-channel gamma counter detector NaI (Tl). Retention factor (R f ) of 131 I-SKA = 0.0 and R f of iodide-131 = 0.6 to 0.9 [12] . 
Characterization of 131 I-SKA
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One of the method radioiodination is the "chlo Chloramine-T is a sodium salt toluene-sulfonamide and is a m Chloramine-T oxidizes iodide species, which then labels the reaction occurs through electrop the aromatic tyrosine chain in is bound to positively charge o group monoiodo or diiodotyr Fig. 3 [16, 17] . A number of analytical detect the radiochemical impur compounds. In this experim 131 I-SKA has been determined chromatography system using W tyrosine or ble for in vivo studies alf life (8 days) and gives low radiation form, iodine binds In protein iodination, s the primary site of SKA has as many as pyMOL software as commonly used in oramine-T method".
of N-monochloro-pmild oxidizing agent.
to a reactive iodine compound [14] . The philic substitution on SKA [16, 17] . Iodine ortho position of the rosine as shown in he crystal structure of (Fig. 4) . Radiochemical purity of 131 I-SKA was calculated based on the count numbers of the peak area of A high labeling yield is always desirable, although it may not be attainable in many cases. Several parameters influenced were varied in order to get optimum condition in SKA labeling. The role of chloramine-T is very important in the radioiodination labeling; however, chloramine-T is a highly reactive substance and can cause denaturation of proteins [14] . The excess oxidizing agent can easily oxidise the molecule beeing labeled, and the addition of sodium metabisulfite can stop the reaction immediately. Table 1 showed the amount of SKA and chloramine-T used in the labeling. The highest labeling yield was obtained with molar ratio between chloramine-T : SKA = 1 : 452 and 60s of incubation time. Irrespective of the radio-labeling methods, the prepared product will require purification before use. To retain the enhanced sensitivity and precision of the biomedical studies, the purity of the label compound needs to be high. Radiochemical and chemical impurities arise from incomplete labeling of compounds and can be separated by various methods. For this reason, the 131 I-SKA as a labeled product was immediately separated from impurities by ion exchange chromatography method. Dowex 1x8 was selected resin that suitable for this purpose. Ion exchange was performed by passing the labeled product through a column ionic resin (Dowex 1x8) and eluting with phosphate buffer. The resin sizes and the diameters of the column were varied in order to obtain high radiochemical purity as shown in Table 2 . The elution can be considerably improved by the presence of sufficient carrier protein (BSA) in the eluting buffer. The result showed that the optimum purification condition (97.7%) obtained by using 100mg Dowex 1x8, 50-100 mesh and 0.5 cm diameter of column. The purification profile of 131 I-SKA, as shown in Fig. 5 and Table 3 , illustrates the fraction number of elution. Radiochemical purity was decreased at the 3 rd until the 5 th fraction (<50%). The highest, both of radioactivity and radiochemical purity was found in the 2 nd fraction. I-SKA bands parallel to unlabeled SKA with molecular weight of 63.8 kDa as also shown by autoradiography method in Fig. 6 . This result proved that SKA has been labeled with iodine-131, and has not degraded during and after labeling. In general, a labeled compound has a self life during which it can be used safely for its intended purpose. The loss of efficacy of a labeled compound over a period of time may result from radiolysis and depends on the physical half life of the radionuclide, the nature of emitted radiations, the solvent, any additive, pH, and the nature of the chemical bond between the radionuclide and the molecule [10, 14, 15] . In this experiment, the stability of labeled 131 I-SKA has been observed in various temperature, at o C and 37 o C for about 3 hours; however, the stability profile at 37 o C was lower than the product stored at room temperature, it may be the increase of temperature will affect the release of iodine atom from tyrosine chain of SKA [19] . 
CONCLUSION
The recombinant streptokinase (SKA) has been successfully labeled with radioiodine-131 using the chloramine-T method. The labeling yield was about 35% with radiochemical purity more than 95%. The labeling yield was not very high, but the method allows iodination without alteration of SKA. The characteristics of 131 I-SKA are suitable and can be used for biological studies such as in pharmacological trials using animal models or in other preclinical assessments.
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